David Li Email

VP Technology, Operation and Support . MedChemExpress

Current Roles

Employees:
87
Revenue:
$75M
About
MedChemExpress has an experienced team of synthesis chemists. Led by excellent scientists, our chemical synthesis team is capable of supporting all kinds of chemistry projects, even multiple step synthesis of complex molecules, such as metabolites and steroids. MedChemExpress has always been committed to develop the most optimized synthetic route and high-quality products that exceed international standards. With rich experiences in preparing a large number of different bioactive molecules, we can provide your customized compounds more rapidly than other companies. Our company is dedicated to providing customers with all kinds of high quality bioactive small molecules, including inhibitors, antagonists, agonists and modulators. We own a comprehensive product line and offer professional after-sale services to achieve customer satisfaction. Our products have been widely used in various fields of biopharmaceutical research and development, especially in the research focus areas such as cancer, infection, autoimmune diseases, diabetes, cardiovascular diseases and neurodegenerative diseases. Our tech-support team classifies products into Apoptosis, Epigenetics, Wnt/Hedgehog/Notch, PI3K/Akt/mTOR, etc., according to the basic biological theory of signaling pathways which cover all aspects of the pathogenesis of diseases.
MedChemExpress Address
1 Deer Park Dr, Suite Q, Monmouth Junction, N
Monmouth Junction, NJ
MedChemExpress Email

#1 Startup Dataset

Growth rates, revenue data, direct competitors and contact details.